Table of Contents

Chapter 1 Methodology And Scope
1.1 Market Segmentation
1.2 Market Definition
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 Gvr’s Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.5 Information Or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.8 List Of Secondary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
Chapter 2 Executive Summary
2.1 Market Snapshot (Regional)
2.2 Segment Snapshot (Treatment And Type)
2.3 Segment Snapshot (End-Use)
2.4 Competitive Landscape
Chapter 3 Diabetic Foot Ulcer Treatment Market Variables And Trends
3.1 Market Lineage Outlook
3.2 Market Dynamics
3.2.1 Market Driver Impact Analysis
3.2.1.1 Increasing Prevalence of Diabetic Foot Ulcer
3.2.1.2 Rising Geriatric Population
3.2.1.3 Increasing Government Initiative
3.2.2 Market Restraint Impact Analysis
3.2.2.1 High Cost of Advanced Wound Care Devices and Therapies
3.3 Industry Analysis Tools
3.3.1 Porter’s Analysis
3.3.2 Macroeconomic Analysis
3.4 Covid-19 Impact Analysis
3.4.1 Post-Pandemic Market Insights
3.5 Supply Chain Analysis
Chapter 4 Diabetic Foot Ulcer Treatment Market: Treatment Analysis
4.1 Treatment Movement Analysis & Market Share, 2022 & 2030
4.2 Diabetic Foot Ulcer Treatment Market Estimates & Forecast, By Treatment (USD Million)
4.3 Market Size & Forecasts And Trend Analysis, 2018 To 2030
4.3.1 Wound Care Dressings
4.3.1.1 Wound Care Dressings Market, 2018 - 2030 (USD Million)
4.3.1.2 Alginate Dressings
4.3.1.2.1 Alginate Dressings Market, 2018 - 2030 (USD Million)
4.3.1.3 Hydrofiber Dressings
4.3.1.3.1 Hydrofiber Dressings Market, 2018 - 2030 (USD Million)
4.3.1.4 Foam Dressings
4.3.1.4.1 Foam Dressings Market, 2018 - 2030 (USD Million)
4.3.1.5 Film Dressing
4.3.1.5.1 Film Dressing Market, 2018 - 2030 (USD Million)
4.3.1.6 Hydrocolloid Dressings
4.3.1.6.1 Hydrocolloid Dressings Market, 2018 - 2030 (USD Million)
4.3.1.7 Surgical Dressings
4.3.1.7.1 Surgical Dressings Market, 2018 - 2030 (USD Million)
4.3.1.8 Hydrogel Dressings
4.3.1.8.1 Hydrogel Dressings Market, 2018 - 2030 (USD Million)
4.3.2 Biologics
4.3.2.1 Biologics Market, 2018 - 2030 (USD Million)
4.3.2.2 Growth Factors
4.3.2.2.1 Growth Factors Market, 2018 - 2030 (USD Million)
4.3.2.3 Skin Grafts
4.3.2.3.1 Skin Grafts Market, 2018 - 2030 (USD Million)
4.3.3 Therapy Devices
4.3.3.1 Therapy Devices Market, 2018 - 2030 (USD Million)
4.3.3.2 Negative Pressure Wound Therapy
4.3.3.2.1 Negative Pressure Wound Therapy Market, 2018 - 2030 (USD Million)
4.3.3.3 Ultrasound Therapy
4.3.3.3.1 Ultrasound Therapy Market, 2018 - 2030 (USD Million)
4.3.4 Antibiotic Medications
4.3.4.1 Antibiotic Medications Market, 2018 - 2030 (USD Million)
4.3.5 Others
4.3.5.1 Others Market, 2018 - 2030 (USD Million)
Chapter 5 Diabetic Foot Ulcer Treatment Market: Ulcer Type
5.1 Type Movement Analysis & Market Share, 2022 & 2030
5.2 Diabetic Foot Ulcer Treatment Market Estimates & Forecast, By Ulcer Type (USD Million)
5.3 Market Size & Forecasts And Trend Analysis, 2018 To 2030
5.3.1 Neuropathic Ulcers
5.3.1.1 Neuropathic Ulcers Market, 2018 - 2030 (USD Million)
5.3.2 Ischemic Ulcers
5.3.2.1 Ischemic Ulcers Market, 2018 - 2030 (USD Million)
5.3.3 Neuro-Ischemic Ulcers
5.3.3.1 Neuro-Ischemic Ulcers Market, 2018 - 2030 (USD Million)
Chapter 6 Diabetic Foot Ulcer Treatment Market: End-Use Analysis
6.1 End-Use Movement Analysis & Market Share, 2022 & 2030
6.2 Diabetic Foot Ulcer Treatment Market Estimates & Forecast, By End-Use (USD Million)
6.3 Market Size & Forecasts And Trend Analysis, 2018 To 2030
6.3.1 Hospitals
6.3.1.1 Hospitals Market, 2018 - 2030 (USD Million)
6.3.2 Ambulatory Surgical Centers
6.3.2.1 Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
6.3.3 Homecare
6.3.3.1 Homecare Market, 2018 - 2030 (USD Million)
Chapter 7 Diabetic Foot Ulcer Treatment Market: Regional Estimates & Trend Analysis
7.1 Diabetic Foot Ulcer Treatment Market: Regional Outlook
7.2 North America
7.2.1 North America Diabetic Foot Ulcer Treatment Market Estimates & Forecasts, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 Key Country Dynamics
7.2.2.2 Competitive Scenario
7.2.2.3 Regulatory Framework
7.2.2.4 Reimbursement Scenario
7.2.2.5 U.S. Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Key Country Dynamics
7.2.3.2 Competitive Scenario
7.2.3.3 Regulatory Framework
7.2.3.4 Reimbursement Scenario
7.2.3.5 Canada Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Europe Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.2 U.K
7.3.2.1 Key Country Dynamics
7.3.2.2 Competitive Scenario
7.3.2.3 Regulatory Framework
7.3.2.4 Reimbursement Scenario
7.3.2.5 U.K Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.3 Germany
7.3.3.1 Key Country Dynamics
7.3.3.2 Competitive Scenario
7.3.3.3 Regulatory Framework
7.3.3.4 Reimbursement Scenario
7.3.3.5 Germany Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.4 France
7.3.4.1 Key Country Dynamics
7.3.4.2 Competitive Scenario
7.3.4.3 Regulatory Framework
7.3.4.4 Reimbursement Scenario
7.3.4.5 France Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Key Country Dynamics
7.3.5.2 Competitive Scenario
7.3.5.3 Regulatory Framework
7.3.5.4 Reimbursement Scenario
7.3.5.5 Italy Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Key Country Dynamics
7.3.6.2 Competitive Scenario
7.3.6.3 Regulatory Framework
7.3.6.4 Reimbursement Scenario
7.3.6.5 Spain Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.7 Sweden
7.3.7.1 Key Country Dynamics
7.3.7.2 Competitive Scenario
7.3.7.3 Regulatory Framework
7.3.7.4 Reimbursement Scenario
7.3.7.5 Sweden Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.8 Denmark
7.3.8.1 Key Country Dynamics
7.3.8.2 Competitive Scenario
7.3.8.3 Regulatory Framework
7.3.8.4 Reimbursement Scenario
7.3.8.5 Denmark Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.9 Norway
7.3.9.1 Key Country Dynamics
7.3.9.2 Competitive Scenario
7.3.9.3 Regulatory Framework
7.3.9.4 Reimbursement Scenario
7.3.9.5 Norway Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Key Country Dynamics
7.4.2.2 Competitive Scenario
7.4.2.3 Regulatory Framework
7.4.2.4 Reimbursement Scenario
7.4.2.5 Japan Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.3 China
7.4.3.1 Key Country Dynamics
7.4.3.2 Competitive Scenario
7.4.3.3 Regulatory Framework
7.4.3.4 Reimbursement Scenario
7.4.3.5 China Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.4 India
7.4.4.1 Key Country Dynamics
7.4.4.2 Competitive Scenario
7.4.4.3 Regulatory Framework
7.4.4.4 Reimbursement Scenario
7.4.4.5 India Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.5 Australia
7.4.5.1 Key Country Dynamics
7.4.5.2 Competitive Scenario
7.4.5.3 Regulatory Framework
7.4.5.4 Reimbursement Scenario
7.4.5.5 Australia Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.6 South Korea
7.4.6.1 Key Country Dynamics
7.4.6.2 Competitive Scenario
7.4.6.3 Regulatory Framework
7.4.6.4 Reimbursement Scenario
7.4.6.5 South Korea Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.7 Thailand
7.4.7.1 Key Country Dynamics
7.4.7.2 Competitive Scenario
7.4.7.3 Regulatory Framework
7.4.7.4 Reimbursement Scenario
7.4.7.5 Thailand Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5 Latin America
7.5.1 Latin America Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Key Country Dynamics
7.5.2.2 Competitive Scenario
7.5.2.3 Regulatory Framework
7.5.2.4 Reimbursement Scenario
7.5.2.5 Brazil Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Key Country Dynamics
7.5.3.2 Competitive Scenario
7.5.3.3 Regulatory Framework
7.5.3.4 Reimbursement Scenario
7.5.3.5 Mexico Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.4 Argentina
7.5.4.1 Key Country Dynamics
7.5.4.2 Competitive Scenario
7.5.4.3 Regulatory Framework
7.5.4.4 Reimbursement Scenario
7.5.4.5 Argentina Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6 Middle East & Africa
7.6.1 Middle East & Africa Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 Key Country Dynamics
7.6.2.2 Competitive Scenario
7.6.2.3 Regulatory Framework
7.6.2.4 Reimbursement Scenario
7.6.2.5 South Africa Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Key Country Dynamics
7.6.3.2 Competitive Scenario
7.6.3.3 Regulatory Framework
7.6.3.4 Reimbursement Scenario
7.6.3.5 Saudi Arabia Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.4 UAE
7.6.4.1 Key Country Dynamics
7.6.4.2 Competitive Scenario
7.6.4.3 Regulatory Framework
7.6.4.4 Reimbursement Scenario
7.6.4.5 UAE Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.5 Kuwait
7.6.5.1 Key Country Dynamics
7.6.5.2 Competitive Scenario
7.6.5.3 Regulatory Framework
7.6.5.4 Reimbursement Scenario
7.6.5.5 Kuwait Diabetic Foot Ulcer Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8 Competitive Analysis
8.1 Company Categorization
8.2 Participants’ Overview
8.3 Financial Performance
8.4 Product Benchmarking
8.5 Company Market Share Analysis, 2023
8.6 Company Market Position Analysis
8.7 Strategy Mapping
8.7.1 Mergers & Acquisitions
8.7.2 New Product Launch
8.7.3 Partnerships & Collaborations
8.7.4 Expansion
8.7.5 Others
8.8 Company Profiles
8.8.1 ConvaTec, Group Plc
8.8.1.1 Company overview
8.8.1.2 Finacial performance
8.8.1.3 Product benchmarking
8.8.1.4 Strategic initiatives
8.8.2 Acelity L.P., Inc.
8.8.2.1 Company overview
8.8.2.2 Finacial performance
8.8.2.3 Product benchmarking
8.8.2.4 Strategic initiatives
8.8.3 3M Health Care
8.8.3.1 Company overview
8.8.3.2 Finacial performance
8.8.3.3 Product benchmarking
8.8.3.4 Strategic initiatives
8.8.4 Coloplast Corp.
8.8.4.1 Company overview
8.8.4.2 Finacial performance
8.8.4.3 Product benchmarking
8.8.4.4 Strategic initiatives
8.8.5 Smith & Nephew Plc
8.8.5.1 Company overview
8.8.5.2 Finacial performance
8.8.5.3 Product benchmarking
8.8.5.4 Strategic initiatives
8.8.6 B. Braun Melsungen AG
8.8.6.1 Company overview
8.8.6.2 Finacial performance
8.8.6.3 Product benchmarking
8.8.6.4 Strategic initiatives
8.8.7 Medline Industries, LP.
8.8.7.1 Company overview
8.8.7.2 Finacial performance
8.8.7.3 Product benchmarking
8.8.7.4 Strategic initiatives
8.8.8 Molnlycke Health Care AB
8.8.8.1 Company overview
8.8.8.2 Finacial performance
8.8.8.3 Product benchmarking
8.8.8.4 Strategic initiatives
8.8.9 Medtronic Plc
8.8.9.1 Company overview
8.8.9.2 Finacial performance
8.8.9.3 Product benchmarking
8.8.9.4 Strategic initiatives
Chapter 9 Analyst Perspective